Outcome of advanced stage (III/IV) intermediate-risk patients with mature B-NHL using rituximab plus FAB group B4 chemotherapy: a Children's Oncology Group report

被引：0

作者：

Goldman, S. ^{[1
]}

Smith, L. ^{[2
]}

Anderson, J. R. ^{[2
]}

Perkins, S. ^{[3
]}

Harrison, L. ^{[4
]}

Shiramizu, B. ^{[9
]}

Sanger, W. ^{[10
]}

Barth, M. ^{[11
]}

Cairo, M. S. ^{[4
,5
,6
,7
,8
]}

机构：

[1] Med City Childrens Hosp, Div Pediat Hematol Oncol, Dallas, TX USA

[2] Univ Nebraska, Coll Publ Hlth, Dept Biostat, Omaha, NE 68182 USA

[3] Univ Utah, Dept Pathol, Salt Lake City, UT USA

[4] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA

[5] New York Med Coll, Dept Med, Valhalla, NY 10595 USA

[6] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA

[7] New York Med Coll, Dept Microbiol, Valhalla, NY 10595 USA

[8] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA

[9] Univ Hawaii, Div Pediat Hematol Oncol, Honolulu, HI 96822 USA

[10] Univ Nebraska Med Ctr, Dept Cytogenet, Omaha, NE USA

[11] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 159卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：24 / 24

页数：1

共 50 条

[21] Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukemia: A Children's Oncology Group (COG) report. [J].

Barth, Matthew John ;

Goldman, Stanton ;

Smith, Lynette ;

Perkins, Sherrie L. ;

Shiramizu, Bruce ;

Gross, Thomas G. ;

Harrison, Lauren ;

Sanger, Warren ;

Geyer, Mark B. ;

Giulino, Lisa B. ;

Cairo, Mitchell S. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)

[22] MINIMAL DISSEMINATED DISEASE/RESIDUAL DISEASE IN CHILDREN AND ADOLESCENTS WITH MATURE B-CELL NON-HODGKIN LYMPHOMA (B-NHL) MAY IMPACT THE RISK OF RELAPSE: A CHILDREN'S ONCOLOGY GROUP REPORT [J].

Shiramizu, B. ;

Goldman, S. ;

Smith, L. ;

Harrison, L. ;

Van De Ven, C. ;

Gross, T. G. ;

Sanger, W. ;

Perkins, S. ;

Cairo, M. S. .

ANNALS OF ONCOLOGY, 2011, 22 :114-114

[23] Relationship of fusion protein status and outcome for children with intermediate-risk rhabdomyosarcoma: A Children's Oncology Group report. [J].

Skapek, Stephen ;

Anderson, James Robert ;

Barr, Frederick G. ;

Bridge, Julia Ann ;

Gastier-Foster, Julie M. ;

Parham, David ;

Rudzinski, Erin R. ;

Triche, Timothy J. ;

Hawkins, Douglas S. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)

[24] INTER-B NHL-RITUX-2010 TRIAL FOR CHILDREN/ADOLESCENTS WITH HIGH-RISK MATURE B-NHL: SAFETY AND EFFICACY IN PATIENTS TREATED WITH RITUXIMAB AND LMB CHEMOTHERAPY [J].

Minard-Colin, V. ;

Auperin, A. ;

Burke, A. ;

Alexander, S. ;

Moreno, M. ;

Buffardi, S. ;

Uyttebroeck, A. ;

Bollard, C. ;

Zsiros, J. ;

Csoka, M. ;

Kazanowska, B. ;

Chiang, A. ;

Verschuur, A. ;

Miles, R. ;

Wotherspoon, A. ;

Barkauskas, D. ;

Wheatley, K. ;

Vassal, G. ;

Adamson, P. ;

Gross, T. ;

Patte, C. ;

Pillon, M. .

LEUKEMIA RESEARCH, 2022, 121 :S43-S43

[25] Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol [J].

A Atra ;

J D Imeson ;

R Hobson ;

M Gerrard ;

I M Hann ;

O B Eden ;

R L Carter ;

C R Pinkerton .

British Journal of Cancer, 2000, 82 :1396-1402

[26] Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol [J].

Atra, A ;

Imeson, JD ;

Hobson, R ;

Gerrard, M ;

Hann, IM ;

Eden, OB ;

Carter, RL ;

Pinkerton, CR .

BRITISH JOURNAL OF CANCER, 2000, 82 (08) :1396-1402

[27] ISOLATED MYC REARRANGEMENT BY CYTOGENETICS/FISH IN CHILDREN AND ADOLESCENTS (C&A) WITH STAGE III/IV B-NHL BM+ AND/OR CNS+ MAY HAVE AN IMPROVED OUTCOMES FOLLOWING IMMUNOCHEMOTHERAPY: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP [J].

Nelson, M. ;

Goldman, S. ;

Harrison, L. ;

Cairo, M. S. ;

Sanger, W. .

ANNALS OF ONCOLOGY, 2011, 22 :175-175

[28] Therapy of Advanced-stage Mature B-cell Lymphoma and Leukemia in Children and Adolescents With Rituximab and Reduced Intensity Induction Chemotherapy (B-NHL 2004M Protocol): The Results of a Multicenter Study [J].

Samochatova, Elena V. ;

Maschan, Alexey A. ;

Shelikhova, Larisa N. ;

Myakova, Natalia V. ;

Belogurova, Margarita B. ;

Khlebnikova, Olga P. ;

Shamardina, Anastasia V. ;

Ryskal, Olga V. ;

Roumiantseva, Julia V. ;

Konovalov, Dmitriy M. ;

Dubrovina, Maria E. ;

Rumyantsev, Alexander G. .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (05) :395-401

[29] A study of rituximab and ifosfamide, carboplatin, etoposide (ICE) chemotherapy in children with recurrent/refractory B-cell non-Hodgkin lymphoma (NHL) and mature B-cell acute lymphoblastic leukemia (B-ALL). A children's oncology group report [J].

Griffin, T. ;

Weitzman, S. ;

Weinstein, H. ;

Chang, M. ;

Hutchison, R. .

ANNALS OF ONCOLOGY, 2008, 19 :109-109

[30] Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group [J].

Casey, Dana L. ;

Chi, Yueh-Yun ;

Donaldson, Sarah S. ;

Hawkins, Douglas S. ;

Tian, Jing ;

Arndt, Carole A. ;

Rodeberg, David A. ;

Routh, Jonathan C. ;

Lautz, Timothy B. ;

Gupta, Abha A. ;

Yock, Torunn, I ;

Wolden, Suzanne L. .

CANCER, 2019, 125 (18) :3242-3248

← 1 2 3 4 5 →